Mechanism of Action of the LAT1 Inhibitor Being Developed by Our Company
NEWS
-
- 2026.04.20
-
JPH034 Phase I Clinical Trial Registered on ClinicalTrials.gov
-
- 2026.04.13
-
Notice of Availability of Webinar Recording Hosted by the Cholangiocarcinoma Foundation – Advancing Understanding of the Global Phase 3 Clinical Trial of Nanvuranlat –
-
- 2026.04.01
-
Notice of Webinar Hosted by the Cholangiocarcinoma Foundation – Advancing Understanding of the Global Phase 3 Clinical Trial of Nanvuranlat –
